Leveraging EHR Data within Drug Development

Chat With Us

*Live Chat is available
 9:00AM - 5:00PM EST.

Access 35+ 
Different Sessions!

View the Tri-Located Agendas:

Clinical Trials Inspection Readiness

eClinical Trial Management

Leveraging EHR within Drug Development

Featured Presentations

THE CHALLENGES OF ESTABLISHING EHR CRITERIA FROM BIOMARKER DATA

• Identifying biomarkers that are integral to the design of the trial
• Evaluate the type of data for biomarkers generated by chemical, molecular, and micro-imaging testing
• Discussing standards in CDISC and HL7 messaging as the precursor to establishing a comprehensive EHR

Terry Katz, VP, Biometrics (Global Statistics and Data Management), ImClone Systems Incorporated

CASE STUDY: EXCHANGING EHR DATA FROM CLINICAL TRIALS TO HOSPITALS 

In case study session, you will hear examples of exchanging data from clinical trials to hospitals; which would be able to create hospital to enhance their capabilities of flagging health records.  

You will hear:

• Strategies to encourage patients and physicians to consider possible participation in a clinical trial as part of their treatment
• Communication techniques to better information patients and physicians about existing opportunities that can act as part of their care
• Adhering to rules and regulations of state government 

Joris Van Dam, Translational Sciences Strategic Project Leader, Novartis Institutes for Biomedical Research

THE CURRENT AND FUTURE USE OF EHRS IN PATIENT RECRUITMENT

• Analyzing the current uses of EHR data and how it is revolutionizing itself to adapt to future developments
• How the use of EHRs are creating advancements in patient recruitment techniques
• Discuss the current use of EHRs in patient recruitment and how to enhance your existing techniques

Jennifer Wulff, Director, Clinical Innovation, Pfizer Worldwide Research & Development